Pharnext
ALPHA | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- FR0011191287 (+4 more)
- LEI:
- 969500KJGF9ZUYXSMJ27
- Country:
- France
- Address:
- 9 RUE DES FILLES SAINT-THOMAS, 75002 PARIS
- Website:
- https://pharnext.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Our company Pharnext is an advanced clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical needs. Our drug Candidates Two drug candidates are currently in clinical development: PXT3003 for the treatment of Charcot-Marie-Tooth disease type 1A and PXT864 for Alzheimer’s disease. Both of our lead assets originated from the Pleotherapy R&D approach.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Pharnext and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-08-27 13:00 |
Legal Proceedings Report
Ouverture d'une procédure de liquidation judiciaire
|
French | 194.1 KB | |
| 2024-08-01 18:00 |
Share Issue/Capital Change
Ajustement de la valeur nominale
|
French | 189.9 KB | |
| 2024-07-18 18:00 |
Capital/Financing Update
Point concernant l'accord de financement en obligations convertibles accordé pa…
|
French | 194.2 KB | |
| 2024-07-15 18:00 |
Legal Proceedings Report
Demande d'ouverture d'une procédure de liquidation judiciaire
|
French | 193.2 KB | |
| 2024-07-10 08:00 |
Capital/Financing Update
Pharnext fait un point sur sa situation financière
|
French | 191.6 KB | |
| 2024-07-04 20:00 |
Legal Proceedings Report
Pharnext annonce la résiliation du contrat de financement accordé par Néovacs
|
French | 232.3 KB | |
| 2024-07-03 08:00 |
Capital/Financing Update
Pharnext fait un point sur les conséquences de sa situation stratégique et fina…
|
French | 208.2 KB | |
| 2024-07-01 18:30 |
Share Issue/Capital Change
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 185.7 KB | |
| 2024-06-28 08:00 |
Legal Proceedings Report
Pharnext fait un point d'étape sur les dernières avancées majeures d'un point d…
|
French | 209.3 KB | |
| 2024-06-18 18:30 |
Post-Annual General Meeting Information
Pharnext annonce la prorogation de la procédure de conciliation jusqu'au 15 jui…
|
French | 194.9 KB | |
| 2024-06-05 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 181.3 KB | |
| 2024-05-29 18:00 |
Share Issue/Capital Change
Ajustement de la valeur nominale
|
French | 190.9 KB | |
| 2024-05-07 19:10 |
Share Issue/Capital Change
Ajustement de la valeur nominale
|
French | 190.6 KB | |
| 2024-05-06 18:00 |
Pre-Annual General Meeting Information
Pharnext convoque ses actionnaires en assemblée générale le 10 juin 2024
|
French | 194.7 KB | |
| 2024-05-02 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 195.4 KB |
Automate Your Workflow. Get a real-time feed of all Pharnext filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Pharnext via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
